Antiplatelet Therapy in Older Adults with Non-ST-Segment Elevation Acute Coronary Syndrome: Considering Risks and Benefits

American Journal of Cardiology

Volumn 104, Issue 5 SUPPL., 2009, Pages 16C-21C

  Lopes, Renato D ^a   Alexander, Karen P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; CYCLOOXYGENASE 1; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PLACEBO; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; TIROFIBAN;

ACUTE CORONARY SYNDROME; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY STENT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; ELDERLY CARE; HEMOSTASIS; HUMAN; KIDNEY CLEARANCE; LOADING DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; ST SEGMENT; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS;

EID: 68749097313     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.021     Document Type: Article

References (33)

1. Gharacholou S.M., and Alexander K.P. Issues with care in the elderly patient presenting with acute ischemia. Curr Heart Fail Rep 3 (2006) 51-56
2. Goldberg R.J., Samad N.A., Yarzebski J., Gurwitz J., Bigelow C., and Gore J.M. Temporal trends (1975-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction (Worcester Heart Attack Study). N Engl J Med 340 (1999) 1162-1168
3. Giugliano R.P., Camargo Jr. C.A., Lloyd-Jones D.M., Zagrodsky J.D., Alexis J.D., Eagle K.A., Fuster V., and O'Donnell C.J. Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines. Arch Intern Med 158 (1998) 1113-1120
4. Alexander K.P., Roe M.T., Chen A.Y., Lytle B.L., Pollack Jr. C.V., Foody J.M., Boden W.E., Smith Jr. S.C., Gibler W.B., Ohman E.M., et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1479-1487
5. Avezum A., Makdisse M., Spencer F., Gore J.M., Fox K.A., Montalescot G., Eagle K.A., White K., Mehta R.H., Knobel E., et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149 (2005) 67-73
6. Patrono C., Baigent C., Hirsh J., Roth G., and American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 suppl (2008) 199S-233S
7. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. [published correction appears in BMJ 2002;324:141]. BMJ 324 (2002) 71-86
8. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. [published correction appears in BMJ 1994;308:1540]. BMJ 308 (1994) 81-106
9. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K., and Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
10. Mehta S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S., et al., Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
11. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F.J., Ardissino D., De Servi S., Murphy S.A., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
12. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338 (1998) 1498-1505
13. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. [published correction appears in N Engl J Med 1998;339:415]. N Engl J Med 338 (1998) 1488-1497
14. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339 (1998) 436-443
15. Giugliano R.P., White J.A., Bode C., Armstrong P.W., Montalescot G., Lewis B.S., van T Hof A., Berdan L.G., Lee K.L., Strony J.T., et al., EARLY ACS Investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) Mar 31. [Epub ahead of print]
16. Gharacholou S.M., and Becker R.C. Hemostasis and thrombosis in older adults. J Thromb Thrombolysis 2 (2009) 249-251
17. Becker R.C. Thrombotic preparedness in aging: a translatable construct for thrombophilias?. J Thromb Thrombolysis 24 (2007) 323-325
18. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., Pippen A.M., Annex B.H., Dong C., and Taylor D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
19. Bauer K.A., Weiss L.M., Sparrow D., Vokonas P.S., and Rosenberg R.D. Aging-associated changes in indices of thrombin generation and protein C activation in humans: Normative Aging Study. J Clin Invest 80 (1987) 1527-1534
20. Mari D., Mannucci P.M., Coppola R., Bottasso B., Bauer K.A., and Rosenberg R.D. Hypercoagulability in centenarians: the paradox of successful aging. Blood 85 (1995) 3144-3149
21. Peters R.J., Mehta S.R., Fox K.A., Zhao F., Lewis B.S., Kopecky S.L., Diaz R., Commerford P.J., Valentin V., Yusuf S., and Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 108 (2003) 1682-1687
22. Subherwal S., Bach R.G., Chen A.Y., Gage B.F., Rao S.V., Newby L.K., Wang T.Y., Gibler W.B., Ohman E.M., Roe M.T., et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 119 (2009) 1873-1882
23. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet 348 (1996) 1329-1339
24. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., Chavey II W.E., Fesmire F.M., Hochman J.S., Levin T.N., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) 652-726
25. Budaj A., Yusuf S., Mehta S.R., Fox K.A., Tognoni G., Zhao F., Chrolavicius S., Hunt D., Keltai M., Franzosi M.G., and Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 106 (2002) 1622-1626
26. Alexander K.P., Newby L.K., Cannon C.P., Armstrong P.W., Gibler W.B., Rich M.W., Van de Werf F., White H.D., Weaver W.D., Naylor M.D., et al., American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115 (2007) 2549-2569
27. Yusuf S., Mehta S.R., Zhao F., Gersh B.J., Commerford P.J., Blumenthal M., Budaj A., Wittlinger T., Fox K.A., and Clopidogrel in Unstable angina to prevent Recurrent Events Trial Investigators. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 107 (2003) 966-972
28. Wiviott S.D., Antman E.M., Gibson C.M., Montalescot G., Riesmeyer J., Weerakkody G., Winters K.J., Warmke J.W., McCabe C.H., Braunwald E., and TRITON-TIMI 38 Investigators. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation 111 (2005) 3366-3373
29. Alexander K.P., Chen A.Y., Roe M.T., Newby L.K., Gibson C.M., Allen-LaPointe N.M., Pollack C., Gibler W.B., Ohman E.M., Peterson E.D., and CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. [published correction appears in JAMA 2006;295:628]. JAMA 294 (2005) 3108-3116
30. Hasdai D., Holmes Jr. D.R., Criger D.A., Topol E.J., Califf R.M., and Harrington R.A. Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 139 (2000) 858-866
31. Boersma E., Harrington R.A., Moliterno D.J., White H., Theroux P., Van de Werf F., de Torbal A., Armstrong P.W., Wallentin L.C., Wilcox R.G., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. [published correction appears in Lancet. 2002;359:2120]. Lancet 359 (2002) 189-198
32. Stone G.W., McLaurin B.T., Cox D.A., Bertrand M.E., Lincoff A.M., Moses J.W., White H.D., Pocock S.J., Ware J.H., Feit F., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 (2006) 2203-2216
33. Lopes R.D., Alexander K.P., Manoukian S.V., Bertrand M.E., Feit F., White H.D., Pollack Jr. C.V., Hoekstra J., Gersh B.J., Stone G.W., et al. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 53 (2009) 1021-1030